REGENTIS BIOMATERIALS LTD. (RGNT) › Cash & EquivalentsREGENTIS BIOMATERIALS LTD. (RGNT) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.Fiscal YearCash & EquivalentsChange YoY2025$7.38M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share